某种肠道细菌
生物
非酒精性脂肪肝
TLR2型
炎症
巨噬细胞极化
非酒精性脂肪性肝炎
促炎细胞因子
免疫学
内科学
脂肪肝
巨噬细胞
肠道菌群
医学
生物化学
TLR4型
疾病
体外
作者
Yuqiu Han,Qi Ling,Li Ming Wu,Xiaosen Wang,Zhifei Wang,Jun Chen,Zhipeng Zheng,Ziyuan Zhou,Longfei Jia,Lanjuan Li,Baohong Wang
出处
期刊:Gut microbes
[Landes Bioscience]
日期:2023-06-22
卷期号:15 (1): 2221485-2221485
被引量:109
标识
DOI:10.1080/19490976.2023.2221485
摘要
Current evidence indicates that the next-generation probiotic Akkermansia muciniphila (A. muciniphila) has therapeutic potential for nonalcoholic fatty liver disease (NAFLD), especially its inflammatory stage known as nonalcoholic steatohepatitis (NASH). However, the mechanisms of A. muciniphila in NASH prevention remain unknown. Here, A. muciniphila supplementation prevented hepatic inflammation in high-fat diet-induced NASH mice, characterized by reduced hepatic proinflammatory macrophages (M1) and γδT and γδT17 cells. Consistently, hepatic M1 and γδT cells were enriched in biopsy-proven NASH patients and high-fat/high-carbohydrate diet-induced NASH mice. Antibiotics reduced hepatic M1, γδT and γδT17 cells in NASH mice. Furthermore, A. muciniphila inhibited intestinal barrier disruption and accordingly downregulated hepatic Toll-like receptor 2 (TLR2) expression in NASH mice. The activation of TLR2 by lipoteichoic acid enriched hepatic γδT17 cells (not M1) in normal diet-fed mice and neutralized the γδT cell-lowering and liver inflammation-protecting effects of A. muciniphila in NASH mice. Additionally, activated γδT cells could promote macrophage polarization via IL−17. Our study first supported that A. muciniphila prevented NASH by modulating TLR2-activated γδT17 cells and further macrophage polarization, facilitating clinical therapeutic applications.
科研通智能强力驱动
Strongly Powered by AbleSci AI